During the 30-day follow-up, symptoms improved, and a decrease was recorded in levels of CXCL10, which has been associated with greater viral load, respiratory insufficiency, pulmonary lesions, and mortality in SARS-CoV-2 infection. Here, CXCL10 is linked to Respiratory insufficiency.